NCT01539447View on ClinicalTrials.gov

Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 16, 2022

Study Completion Date

March 16, 2022

Conditions
Heterotopic Ossification
Interventions
DRUG

Naproxen

• Group 1: Naproxen 500 mg twice daily for three weeks following surgery beginning postoperative day #1

DRUG

placebo

• Group 2: Placebo twice daily for three weeks following surgery beginning postoperative day #1

Trial Locations (1)

84108

University of Utah Orthopedics Center, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01539447 - Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy | Biotech Hunter | Biotech Hunter